Successful Treatment of Pandrug-resistant Klebsiella pneumoniae Infection With Ceftazidime-avibactam in a Preterm Infant A Case Report

被引：29
|
作者：
Coskun, Yesim [1 ]
Atici, Serkan [2 ]
机构：
[1] Bahcesehir Univ, Sch Med, Med Pk Gortepe Hosp, Dept Pediat, E5 Uzeri,23 Nisan Sok Merdivenkoy Mah 17, TR-34732 Istanbul, Turkey
[2] Okan Univ, Sch Med, Dept Pediat, Div Pediat Infect Dis, Istanbul, Turkey
来源：
PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2020年 / 39卷 / 09期
关键词：
ceftazidime-avibactam; Klebsiella pneumoniae; preterm infant;
D O I：
10.1097/INF.0000000000002807
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Pandrug-resistant (PDR) bacterial infections in intensive care units are emerging as a severe problem. Therefore, new antibiotic options are urgently needed for the treatment of PDR infections in pediatric age groups, especially neonates. Herein, we report a 25 days old preterm neonate successfully treated with ceftazidime-avibactam due to a urinary tract infection caused by PDRKlebsiella pneumoniae. We aimed to describe our experiences about the safety and efficacy of ceftazidime-avibactam treatment.
引用
收藏
页码：854 / 856
页数：3
相关论文
共 50 条
  • [31] Successful treatment of ventriculitis caused by Pseudomonas aeruginosa and carbapenem-resistant Klebsiella pneumoniae with i.v. ceftazidime-avibactam and intrathecal amikacin
    Gofman, Natalie
    To, Kim
    Whitman, Marc
    Garcia-Morales, Edgar
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2018, 75 (13) : 953 - 957
  • [32] Avibactam/ceftazidimeEmergence of avibactam/ceftazidime resistance in KPC-2 producing Klebsiella pneumoniae infection: case report
    Reactions Weekly, 2019, 1768 (1) : 60 - 60
  • [33] First Report of Ceftazidime-Avibactam Resistance in a KPC-3-Expressing Klebsiella pneumoniae Isolate
    Humphries, Romney M.
    Yang, Shangxin
    Hemarajata, Peera
    Ward, Kevin W.
    Hindler, Janet A.
    Miller, Shelley A.
    Gregson, Aric
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (10) : 6605 - 6607
  • [34] Ceftazidime-Avibactam in Combination with In Vitro Non-susceptible Antimicrobials Versus Ceftazidime-Avibactam in Monotherapy in Critically Ill Patients with Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective Cohort Study
    Guanhao Zheng
    Jianxin Zhang
    Bei Wang
    Jiaqi Cai
    Lili Wang
    Kaixuan Hou
    Yan Zhang
    Liang Zhang
    Zhitao Yang
    Juan He
    Xiaolan Bian
    Infectious Diseases and Therapy, 2021, 10 : 1699 - 1713
  • [35] Ceftazidime-Avibactam in Combination with In Vitro Non-susceptible Antimicrobials Versus Ceftazidime-Avibactam in Monotherapy in Critically Ill Patients with Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective Cohort Study
    Zheng, Guanhao
    Zhang, Jianxin
    Wang, Bei
    Cai, Jiaqi
    Wang, Lili
    Hou, Kaixuan
    Zhang, Yan
    Zhang, Liang
    Yang, Zhitao
    He, Juan
    Bian, Xiaolan
    INFECTIOUS DISEASES AND THERAPY, 2021, 10 (03) : 1699 - 1713
  • [36] Efficacy of ceftazidime-avibactam in the treatment of carbapenem-resistant Klebsiella pneumoniae infections: Focus on solid organ transplantation recipients
    Hu, Juan
    Zha, Lei
    Yu, Yong-Wei
    Su, Qun
    Fang, Xue-Ling
    Ji, Jin-Ru
    Shen, Ping
    Chen, Yun-Bo
    Zheng, Xia
    Xiao, Yong-Hong
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2024, 63 (05)
  • [37] Avibactam/ceftazidime/meropenemDevelopment of resistance in KPC-producing Klebsiella pneumoniae infection: case report
    Reactions Weekly, 2018, 1709 (1) : 42 - 42
  • [38] Antibacterial Activity and Optimal Treatment of Ceftazidime-Avibactam and Aztreonam-Avibactam Against Bloodstream Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae
    Yu, Wei
    Chen, Yunbo
    Shen, Ping
    Ji, Jinru
    Ying, Chaoqun
    Liu, Zhiying
    Xiong, Luying
    Qiu, Yunqing
    Xiao, Yonghong
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [39] Overexpression of KPC contributes to ceftazidime-avibactam heteroresistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae
    Li, Yitan
    Chen, Xiandi
    Guo, Yingyi
    Lin, Yingzhuo
    Wang, Xiaohu
    He, Guohua
    Wang, Mingzhen
    Xu, Jianbo
    Song, Mingdong
    Tan, Xixi
    Zhuo, Chao
    Lin, Zhiwei
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [40] In Vitro Activity of Ceftazidime-avibactam and Colistin Against Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates
    Hosbul, Tugrul
    Aydogan, Canset Nur
    Kaya, Sinem
    Bedir, Orhan
    Gumral, Ramazan
    Albay, Ali
    MIKROBIYOLOJI BULTENI, 2022, 56 (02): : 218 - 229
12345